Adult liver cancer is the third leading cause of cancer deaths worldwide. The major risk factor for liver cancer is hepatitis B virus (HBV) infection. The purpose of the study is to sequence the HBV genome in patients with chronic HBV infection, and in patients with liver cancer resulting from chronic HBV infection. The goal is to identify mutations in the HBV genome that predisposes these high risk individuals to the development of liver cancer.
Study Type
OBSERVATIONAL
Enrollment
135
Stanford University School of Medicine
Stanford, California, United States
identify mutations in the hepatitis B virus genome that predisposes these high risk individuals to the development of liver cancer
We will be using blood specimens collected through another protocol
Time frame: one time
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.